Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Clinical Services and Resources for the National Institute…

U.S. Department Of Health And Human Services·Maryland

Clinical Services and Resources for the National Institute on Drug Abuse, Intramural Research Program (NIDA, IRP)

Closes 11/28/2025$1M – $5MSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institute on Drug Abuse (NIDA) is issuing a notice of intent to award a sole source contract to Johns Hopkins Bayview Medical Center, Inc. to extend the period of performance for the clinical services and resources necessary to maintain the research operation of the NIDA IRP Clinical Research Program. The contract will be for an additional 12 months, from January 1, 2026, to December 31, 2026. The Government has determined that Johns Hopkins Bayview Medical Center is the only vendor in the marketplace that can provide the services required by NIDA. • The contract is for clinical services and resources necessary to maintain the research operation of the NIDA IRP Clinical Research Program. • The contract period is for 12 months, from January 1, 2026, to December 31, 2026. • The Government has determined that Johns Hopkins Bayview Medical Center is the only vendor that can provide the required services. • Interested parties may identify their interest and capability to respond to the requirement, but the Government shall consider all responses received within 10 days of the posting.

Attached files

Contact

Scott Duernberger(Contract Specialist)

[email protected]

(301) 594-0670

Key dates

Opened
11/18/2025
Closes
11/28/2025
Duration
12 months

Last updated

Details

Type
Sole Source
Industry
Healthcare and Medical Services
NAICS
622110
Solicitation №
75N95026R00002

Budget estimate

$1,000,000 – $5,000,000

The budget for this opportunity is not explicitly stated in the document. However, based on the fact that it is a sole source contract for clinical services and resources for a research program, the budget could be substantial. The contract is for 12 months, which suggests a significant commitment of resources. Considering the scope of the project and the fact that it is a sole source contract, the budget could be in the range of $1 million to $5 million per year, depending on the specific services and resources required.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 77%

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Closes 8/21/2028Opened 5/13/2025

U.S. National Institutes of Health·United States of America

75% match

NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

Closes 11/13/2026Opened 1/3/2024

U.S. National Institutes of Health·United States of America

75% match

NIDA Avenir Program: Fundamental Mechanistic Research in Addiction Science

Closes 5/25/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

74% match

Specialized Alcohol Research Centers (P50 Clinical trial Optional)

Closes 1/27/2027Opened 1/30/2026

U.S. National Institutes of Health·United States of America

74% match

Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)

Closes 2/8/2027Opened 9/11/2025

U.S. National Institutes of Health·United States of America

74% match

Single Source: Institutional Development Award (IDeA) Clinical Research Resource Center (I-CRRC)

Closes 9/27/2027Opened 5/27/2026

U.S. National Institutes of Health·United States of America

73% match

NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 8/13/2024

U.S. National Institutes of Health·United States of America

72% match

HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

Closes 2/9/2029Opened 6/4/2026

U.S. National Institutes of Health·United States of America

72% match

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

Closes 8/11/2027Opened 12/30/2024

U.S. National Institutes of Health·United States of America

72% match

HIV/AIDS Clinical Trials Network Laboratory Centers

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

72% match

Clinical Data, Safety and Statistical Centers (CDSSC)

Closes 5/31/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

72% match

Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories

Closes 9/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

72% match

NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)

Closes 9/25/2027Opened 9/24/2024

U.S. National Institutes of Health·United States of America

71% match

HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)

Closes 1/26/2027Opened 7/17/2025

U.S. National Institutes of Health·United States of America

71% match

NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)

Closes 5/31/2027Opened 7/2/2026

U.S. Department Of Health And Human Services·United States of America

71% match

Synthesis and Distribution of Drugs of Abuse and Related Compounds

Closes 11/20/2026Opened 10/29/2026

U.S. National Institutes of Health·United States of America

71% match

Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)

Closes 5/7/2027Opened 8/16/2023

U.S. National Institutes of Health·United States of America

71% match

HIV/AIDS Clinical Trials Network Statistical and Data Management Centers

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

71% match

AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)

Closes 5/24/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

71% match

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

Closes 12/3/2027Opened 12/5/2024

U.S. Department Of Health And Human Services·Maryland

71% match

NIA:Non-Competitive Combined Synopsis/Solicitation

Closes 11/6/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

71% match

Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 5/28/2027Opened 12/22/2025

U.S. National Institutes of Health·United States of America

71% match

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

Closes 3/6/2027Opened 8/2/2024

U.S. National Institutes of Health·United States of America

71% match

Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)

Closes 1/9/2029Opened 6/9/2025

U.S. National Institutes of Health·United States of America

71% match

Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional)

Closes 9/24/2027Opened 10/6/2026